adavivint,
N-(5-((3Z)-3-(7-(3-fluorophenyl)imidazo(4,5-c)pyridin-2-ylidene)-1,2-dihydroindazol-5-yl)pyridin-3-yl)-3-methylbutanamide,
SM04690,
Adavivint,
UNII-42EK42WHI5,
42EK42WHI5,
1467093-03-3,
SM04690,
N-(5-(3-(7-(3-Fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide,
lorecivivint,
Adavivint [INN],
Adavivint; SM04690,
GTPL9620,
SCHEMBL15302155,
EX-A2711,
AKOS030527966,
ACN-053852,
SM-04690,
SM0-4690,
HY-109049,
CS-0031495,
N-(5-(3-(7-(3-Fluorophenyl)-3H-imidazo(4,5-C)pyridin-2-yl)-1H-indazol-5- yl)-pyridin-3-yl)-3-methylbutanamide,
N-(5-{3-[7-(3-fluorophenyl)-1H-imidazo[4,5-c]pyridin-2-yl]-1H-indazol-5-yl}pyridin-3-yl)-3-methylbutanamide,